CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 94 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $201,000 | -60.5% | 40,300 | 0.0% | 0.00% | – |
| Q4 2020 | $509,000 | +28.5% | 40,300 | 0.0% | 0.00% | – |
| Q3 2020 | $396,000 | -1.2% | 40,300 | 0.0% | 0.00% | – |
| Q2 2020 | $401,000 | +26.1% | 40,300 | +11.9% | 0.00% | – |
| Q1 2020 | $318,000 | -4.2% | 36,000 | 0.0% | 0.00% | – |
| Q4 2019 | $332,000 | +56.6% | 36,000 | 0.0% | 0.00% | – |
| Q3 2019 | $212,000 | -50.9% | 36,000 | 0.0% | 0.00% | – |
| Q2 2019 | $432,000 | +30.9% | 36,000 | +31.9% | 0.00% | – |
| Q1 2019 | $330,000 | +3.4% | 27,300 | +7.5% | 0.00% | – |
| Q4 2018 | $319,000 | -7.8% | 25,400 | +9.0% | 0.00% | – |
| Q3 2018 | $346,000 | -7.0% | 23,300 | +5.4% | 0.00% | – |
| Q2 2018 | $372,000 | -8.1% | 22,100 | +24.9% | 0.00% | – |
| Q1 2018 | $405,000 | +13.4% | 17,700 | +28.3% | 0.00% | – |
| Q4 2017 | $357,000 | +94.0% | 13,800 | +10.4% | 0.00% | – |
| Q3 2017 | $184,000 | +5.7% | 12,500 | 0.0% | 0.00% | – |
| Q2 2017 | $174,000 | – | 12,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |